Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Odaily Noon News

Odaily Noon News

Odaily星球日报Odaily星球日报2026/07/01 05:31
Show original

1. CRCL has been removed from several Russell Growth Indexes, including Russell 1000 and Russell 3000;

2. dYdX may launch a new product, with its token surging over 35% at one point;

3. Samsung Electronics announced 2nm process technology and an AI semiconductor ecosystem cooperation plan;

4. "White-haired stock god" Serenity: Semiconductor supply chain bottlenecks are intensifying, packaging and testing companies are raising prices;

5. SIVE completed a new round of financing of 700 million Swedish krona, and Serenity stated it may be entering a turning point for large-scale growth;

6. On Polymarket, the probability that "Claude Fable 5 will resume service for U.S. customers before July 1" has risen to 97%, up 71% in 24 hours;

7. After previously making over $7.7 million in profit, a whale leveraged 1x long on 16,704 ZEC;

8. After holding for more than 5 months and losing $4.33 million, a whale sold 2,468 ETH.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

智通财经•2026/10/26 04:20
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks

Goldman Sachs stated that the Japanese yen has become a better tool for hedging against AI shocks, with policy shifts reducing the risk of depreciation. The bank recommends shorting USD/JPY and EUR/JPY.

智通财经•2026/10/26 03:41
Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks